390 likes | 502 Vues
This presentation explores the development of systems at Vanderbilt University Medical Center (VUMC) to optimize blood product utilization in pediatric cardiac surgery. Dr. Gina Whitney discusses evidence-based practices, the impact of transfusion protocols on patient outcomes, and the necessity to address transfusion-related complications. Emphasizing standardization and continuous feedback, the session covers metrics for improving blood product utilization with hopes of reducing costs and enhancing patient care. Challenges, lessons learned, and future directions are also highlighted.
E N D
Blood Utilization at VUMC: Developing Systems Which Shape High Quality Care Gina Whitney, M.D. Departments of Anesthesiology and Pediatrics
Beginnings • Philosophical – • Developing a model by which postoperative outcomes inform intraoperative practice • Practical • Giving a large quantity of blood products intra-operatively • “Empiric” transfusion practice • Epidemic of “capillary leak” and prolonged ventilator dependence post-operatively Perioperative Blood Product Utilization in Pediatric Cardiac Surgery
5 units 6+ units
Two ventricle repairs without arch reconstruction • April 1996 – July 2004 • 270 patients • Looked at intraoperative blood products • 4-34 ml/kg LOW • 35-67 ml/kg MEDIUM • 68-364 ml/kg HIGH • Measured DMV
The Quality Case: PRBC transfusion is associated with dose-dependent increases in • surgical site infection • ventilator associated pneumonia • duration of mechanical ventilation • length of stay • mortality
Why (else) should we care about PRBC transfusion? FINANCIAL ALL BLOOD PRODUCTS >12, 700 TRANSFUSIONS in 2010 - VCH, ALL PRODUCTS ANNUAL FACTOR 7 UTILIZATION ~1 MILLION DOLLARS
Some problems are so complex that you have to be highly intelligent and well informed just to be undecided about them. -Laurence J. Peter
Red Cell Transfusion Implementation Period P=0.001
Cryoprecipitate Transfusion Implementation Period P<0.001
Balancing Measure – Chest Tube Output Age < 180 days Age > 180 days
Touchpoint: OR Exit Criteria • ABG within 30 min of leaving room • pH >7.3 • Lactate <10 • CT Output < 3 cc/kg/15min • Inotrope requirement • Epi <0.05 mcg/kg/min • Dopamine <10 mcg/kg/min • Debriefing performed
Lessons Learned • Creating standard practice establishes expectations about evidence based management and clinical course. • Perfect is the enemy of the good. • Move towards problems and not away from them. • Replicate successes. • Lynda.com
Identifying Challenges • Need for evidence-based algorithm to determine appropriateness of PRBC transfusion • Metrics unclear • Attribution of PRBC transfusion to the incorrect attending physicians • “Drive by” transfusions • Need for education regarding transfusion risk
How important are systems? • Ann ThoracSurg 2012 Oct 3 • 12 regional hospitals • Transfusion practice following CAB from Jan 2008 – June 2011 • Surgeon identity accounted for 30% of practice variation • Institution identity accounted for 70% of variation in practice
Next steps • Identified pilot ICU’s at both MCJCHV and VUH • Literature Search • Development of evidence based PRBC transfusion protocol (adult CVICU, trauma ICU) • Modification of existing CPOE system • “Transfuse and reassess” practice • Warn provider of off protocol transfusion • Attribution of transfusion decision to the correct attending physician
Define Best Practice Implemented August 2011
Is our PRBC transfusion practice safer today than it was twelve months ago?
Future Directions • Establish “True North” Metrics • Mutual accountability • Blood utilization metrics are relevant, up to date • Ongoing collaboration with providers (feedback, data and refinement of existing practices) • Establish partnerships with locations with high utilization and low adherence to established EB practices • Target resources to areas of greatest opportunity • Transparency